Advancements in the use of cancer nanovaccines: Comprehensive insights with focus on lung and colon cancer
Cancer remains a prima facie cause of morbidity and mortality globally, necessitating efficient medicaments. The inter-mechanisms between immune system cascade and the ability of cancer cells to evade immunological responses pose a significant challenge in developing effective cancer treatments desp...
Saved in:
| Main Authors: | Qian Li, Shi Jingjuan, Pei Chang, Hu Jian, Han Wen, Yu Le, Chu Hanguang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2025-05-01
|
| Series: | Nanotechnology Reviews |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/ntrev-2025-0167 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy
by: Yijie Wang, et al.
Published: (2024-09-01) -
Emerging Cationic Nanovaccines
by: Ana Maria Carmona-Ribeiro, et al.
Published: (2024-10-01) -
Biomimetic nanovaccines in cancer therapy: mechanisms, efficacy, and clinical translation
by: Dilinaer Wusiman, et al.
Published: (2025-10-01) -
Nanovaccines against Cervical Cancer: Reliable Strategies to Circumvent Limitations of Traditional Therapeutic Vaccines
by: Enwa Felix Oghenemaro, et al.
Published: (2025-04-01) -
CpG‐Based Nanovaccines Enhance Ovarian Cancer Immune Response by Gbp2‐Mediated Remodeling of Tumor‐Associated Macrophages
by: Jiaqiang Xiong, et al.
Published: (2025-04-01)